State Of Wyoming Beam Therapeutics Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$29.86 - $62.36 $21,767 - $45,460	-729 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$53.73 - $82.16 $13,486 - $20,622	251 Added 52.51%	729 $42,000
Q4 2021 Feb 11, 2022	BUY	$68.02 - $99.06 $5,237 - $7,627	77 Added 19.2%	478 $38,000
Q3 2021 Feb 11, 2022	SELL	$84.37 - $133.6 $31,554 - $49,966	-374 Reduced 48.26%	401 $35,000
Q2 2021 Feb 11, 2022	BUY	$64.12 - $128.71 $20,390 - $40,929	318 Added 69.58%	775 $100,000

Q1 2021 Feb 08, 2022	BUY	$71.28 - $120.75 $32,574 - $55,182	457 New	457 $37,000

241

65.6M

311K

777K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.65B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.